{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:45:31Z","timestamp":1773967531815,"version":"3.50.1"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The coronavirus disease 2019 (COVID-19) pandemic, instigated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has profoundly impacted healthcare infrastructures around the globe. While children are usually asymptomatic or have mild symptoms, children with pre-existing kidney conditions require specialized attention. This pivotal report, championed by the International Pediatric Nephrology Association (IPNA), delivers precise and actionable recommendations tailored for pediatric patients with kidney ailments in this pandemic landscape. Central to our findings are rigorous infection control protocols. These are particularly stringent in high-risk zones, emphasizing telehealth\u2019s indispensable role, the significance of curtailing in-person consultations, and the imperative of following rigorous guidelines in regions with heightened COVID-19 prevalence. Additionally, the report delves into vaccination approaches for children with kidney issues, highlighting that the choice of vaccine is often governed by regional accessibility and policy frameworks, rather than a universal preference. A notable observation is the potential correlation between COVID-19 vaccines and specific kidney disorders. However, establishing a direct causal link remains elusive. In summary, our research accentuates the critical need for specialized pediatric kidney care during global health crises and reaffirms the continuous research imperative, especially regarding vaccination ramifications.<\/jats:p>","DOI":"10.1007\/s00467-024-06565-5","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T11:56:50Z","timestamp":1735473410000},"page":"1795-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IPNA clinical practice recommendations on care of pediatric patients with pre-existing kidney disease during seasonal outbreak of COVID-19"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4291-8536","authenticated-orcid":false,"given":"Khalid A.","family":"Alhasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupesh","family":"Raina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"Bonilla-Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidharth K.","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser S.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad-Hani","family":"Temsah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Exantus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samina A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Duzova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Vasudevan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mignon","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upton","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Filler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Montini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the International Pediatric Nephrology Association","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matko","family":"Marlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Morello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Dharnidharka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa F.","family":"Ashoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Trnka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanel","family":"Prestidge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Hari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukta","family":"Mantan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Ignacio","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime M.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilzete Liberato","family":"Bresolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Safouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Bhimma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashir","family":"Admani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Esezobor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"key":"6565_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2174\/1573396317666210924121550","volume":"17","author":"YM Campos","year":"2021","unstructured":"Campos YM, Drumond ALV, de Matos GM et al (2021) Renal involvement in pediatric patients with COVID-19: an up-to-date review. Curr Pediatr Rev 17:253\u2013263. https:\/\/doi.org\/10.2174\/1573396317666210924121550","journal-title":"Curr Pediatr Rev"},{"key":"6565_CR2","doi-asserted-by":"publisher","first-page":"894","DOI":"10.6002\/ect.2021.0275","volume":"19","author":"B Saeed","year":"2021","unstructured":"Saeed B (2021) Impact of COVID-19 Pandemic on management of pediatric kidney transplant recipients. Exp Clin Transplant 19:894\u2013898","journal-title":"Exp Clin Transplant"},{"key":"6565_CR3","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s13312-020-1893-8","volume":"57","author":"A Vasudevan","year":"2020","unstructured":"Vasudevan A, Mantan M, Krishnamurthy S et al (2020) Managing children with renal diseases during the COVID-19 pandemic. Indian Pediatr 57:641\u2013651. https:\/\/doi.org\/10.1007\/s13312-020-1893-8","journal-title":"Indian Pediatr"},{"key":"6565_CR4","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1002\/hsr2.386","volume":"4","author":"N Sabetkish","year":"2021","unstructured":"Sabetkish N, Rahmani A (2021) The overall impact of COVID-19 on healthcare during the pandemic: a multidisciplinary point of view. Health Sci Rep 4:e386","journal-title":"Health Sci Rep"},{"key":"6565_CR5","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.3390\/math11163520","volume":"11","author":"M Heydari","year":"2023","unstructured":"Heydari M, Lai KK (2023) Post-COVID-19 Pandemic era and sustainable healthcare: organization and delivery of health economics research (Principles and Clinical Practice). Mathematics 11:3520. https:\/\/doi.org\/10.3390\/math11163520","journal-title":"Mathematics"},{"key":"6565_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/vaccines11020288","volume":"11","author":"S Thompson","year":"2023","unstructured":"Thompson S, Meyer JC, Burnett RJ, Campbell SM (2023) Mitigating vaccine hesitancy and building trust to prevent future measles outbreaks in England. Vaccines (Basel) 11:288","journal-title":"Vaccines (Basel)"},{"key":"6565_CR7","doi-asserted-by":"publisher","first-page":"e48046","DOI":"10.7759\/cureus.48046","volume":"15","author":"R Naik","year":"2023","unstructured":"Naik R, Avula S, Palleti SK et al (2023) From emergence to endemicity: a comprehensive review of COVID-19. Cureus 15:e48046. https:\/\/doi.org\/10.7759\/cureus.48046","journal-title":"Cureus"},{"key":"6565_CR8","doi-asserted-by":"publisher","first-page":"205435812199013","DOI":"10.1177\/2054358121990135","volume":"8","author":"A Alabbas","year":"2021","unstructured":"Alabbas A, Kirpalani A, Morgan C et al (2021) Canadian Association of Paediatric Nephrologists COVID-19 rapid response: guidelines for management of acute kidney injury in children. Can J Kidney Health Dis 8:2054358121990135","journal-title":"Can J Kidney Health Dis"},{"key":"6565_CR9","unstructured":"World Health Organization (2023) Indicator metadata registry list. https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/193. Accessed 16 Oct 2023"},{"key":"6565_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7326\/M16-1565","volume":"166","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yang K, Maru\u0161ic A et al (2017) A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med 166:128\u2013132","journal-title":"Ann Intern Med"},{"key":"6565_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R et al (2011) GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol 64:395\u2013400. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.012","journal-title":"J Clin Epidemiol"},{"key":"6565_CR12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1542\/peds.2004-1260","volume":"114","author":"American Academy of Pediatrics Steering Committee on Quality Improvement and Management","year":"2004","unstructured":"American Academy of Pediatrics Steering Committee on Quality Improvement and Management (2004) Steering committee on quality improvement and management; classifying recommendations for clinical practice guidelines. Pediatrics 114:874\u2013877. https:\/\/doi.org\/10.1542\/peds.2004-1260","journal-title":"Pediatrics"},{"key":"6565_CR13","unstructured":"World Health Organization (2022) COVID-19 vaccines. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/covid-19-vaccines. Accessed 10 September 2023"},{"key":"6565_CR14","unstructured":"Centers for Disease Control and Prevention (2023) Vaccines for COVID-19. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/index.html. Accessed 7 September 2024"},{"key":"6565_CR15","unstructured":"National Health Service (2022) COVID-19 vaccination. https:\/\/www.nhs.uk\/conditions\/covid-19\/covid-19-vaccination\/. Accessed 7 September 2024"},{"key":"6565_CR16","unstructured":"U.S. FDA (2023) Vaccines and related biological products advisory committee October 5, 2023 Meeting Announcement. https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/vaccines-and-related-biological-products-advisory-committee-october-5-2023-meeting-announcement. Accessed 5 October 2023"},{"key":"6565_CR17","unstructured":"UK Health Security Agency (2023) Coronavirus (COVID-19) vaccination information for public health professionals. https:\/\/www.gov.uk\/government\/publications\/covid-19-the-green-book-chapter-14a. Accessed 7 September 2024"},{"key":"6565_CR18","unstructured":"Koshy J (2020) Coronavirus | U.K. approves Oxford vaccine. India\u2019s drug regulators, in a meeting convened just hours after the approval, reviewed an application by Serum Institute of India for emergency use of jab. https:\/\/www.thehindu.com\/sci-tech\/health\/uk-becomes-first-country-to-approve-astrazeneca-oxford-vaccine-for-covid-19\/article33451081.ece. Accessed 7 September 2024"},{"key":"6565_CR19","unstructured":"VIPER Group COVID19 Vaccine Tracker Team (2023) 8 Vaccines approved for use in China. https:\/\/covid19.trackvaccines.org\/country\/china\/. Accessed 7 September 2024"},{"key":"6565_CR20","doi-asserted-by":"publisher","first-page":"100274","DOI":"10.1016\/j.lanepe.2021.100274","volume":"12","author":"M Makris","year":"2022","unstructured":"Makris M, Pavord S (2022) Most cases of thrombosis and thrombocytopenia syndrome (TTS) post ChAdOx-1 nCov-19 are vaccine-induced immune thrombotic thrombocytopenia (VITT). Lancet Reg Health Eur 12:100274","journal-title":"Lancet Reg Health Eur"},{"key":"6565_CR21","doi-asserted-by":"publisher","first-page":"20471","DOI":"10.1038\/s41598-023-47486-x","volume":"13","author":"N Ab Rahman","year":"2023","unstructured":"Ab Rahman N, Lim MT, Lee FY et al (2023) Thrombocytopenia and venous thromboembolic events after BNT162b2, CoronaVac, ChAdOx1 vaccines and SARS-CoV-2 infection: a self-controlled case series study. Sci Rep 13:20471","journal-title":"Sci Rep"},{"key":"6565_CR22","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","volume":"384","author":"M Scully","year":"2021","unstructured":"Scully M, Singh D, Lown R et al (2021) Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med 384:2202\u20132211","journal-title":"N Engl J Med"},{"key":"6565_CR23","doi-asserted-by":"publisher","unstructured":"Bajema KLDR, Evener SL et al (2021) Comparative effectiveness and antibody responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans \u2014 Five Veterans Affairs Medical Centers, United States. MMWR Morb Mortal Wkly Rep 70:1700\u20131705. https:\/\/doi.org\/10.15585\/mmwr.mm7049a2","DOI":"10.15585\/mmwr.mm7049a2"},{"key":"6565_CR24","doi-asserted-by":"publisher","first-page":"e2124331","DOI":"10.1001\/jamanetworkopen.2021.24331","volume":"4","author":"NE Richards","year":"2021","unstructured":"Richards NE, Keshavarz B, Workman LJ et al (2021) Comparison of SARS-CoV-2 antibody response by age among recipients of the BNT162b2 vs the mRNA-1273 vaccine. JAMA Netw Open 4:e2124331","journal-title":"JAMA Netw Open"},{"key":"6565_CR25","doi-asserted-by":"publisher","first-page":"69769","DOI":"10.1016\/j.kint.2021.07.004","volume":"100","author":"RA Kaiser","year":"2021","unstructured":"Kaiser RA, Haller MC, Apfalter P et al (2021) Comparison of BNT162b2 (Pfizer-BioNtech) and mRNA-1273 (Moderna) SARS-CoV-2 mRNA vaccine immunogenicity in dialysis patients. Kidney Int 100:69769\u201369778. https:\/\/doi.org\/10.1016\/j.kint.2021.07.004","journal-title":"Kidney Int"},{"key":"6565_CR26","doi-asserted-by":"publisher","first-page":"e0116221","DOI":"10.1128\/Spectrum.01162-21","volume":"9","author":"JG Montoya","year":"2021","unstructured":"Montoya JG, Adams AE, Bonetti V et al (2021) Differences in IgG antibody responses following BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines. Microbiol Spectr 9:e0116221","journal-title":"Microbiol Spectr"},{"key":"6565_CR27","unstructured":"Moore DL (2023) COVID-19 vaccine for children and adolescents. Canadian Paediatric Society Infectious Diseases and Immunization Committee. https:\/\/cps.ca\/en\/documents\/position\/covid-19-vaccine-for-children-and-adolescents. Accessed 7 September 2024"},{"key":"6565_CR28","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1001\/jama.2021.15125","volume":"326","author":"D Steensels","year":"2021","unstructured":"Steensels D, Pierlet N, Penders J et al (2021) Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273. JAMA 326:1533\u20131535. https:\/\/doi.org\/10.1001\/jama.2021.15125","journal-title":"JAMA"},{"key":"6565_CR29","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1002\/cncr.33598","volume":"127","author":"MC Woodfield","year":"2021","unstructured":"Woodfield MC, Pergam SA, Shah PD (2021) Cocooning against COVID-19: The argument for vaccinating caregivers of patients with cancer. Cancer 127:2861\u20132863","journal-title":"Cancer"},{"key":"6565_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/cid\/ciq001","volume":"52","author":"CM Healy","year":"2011","unstructured":"Healy CM, Rench MA, Baker CJ (2011) Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 52:157\u2013162. https:\/\/doi.org\/10.1093\/cid\/ciq001","journal-title":"Clin Infect Dis"},{"key":"6565_CR31","doi-asserted-by":"publisher","first-page":"ofad200","DOI":"10.1093\/ofid\/ofad200","volume":"10","author":"D Kabbani","year":"2023","unstructured":"Kabbani D, Yotis DM, Ferreira VH et al (2023) Immunogenicity, safety, and breakthrough severe acute respiratory syndrome coronavirus 2 infections after coronavirus disease 2019 vaccination in organ transplant recipients: a prospective multicenter Canadian study. Open Forum Infect Dis 10:ofad200","journal-title":"Open Forum Infect Dis"},{"key":"6565_CR32","doi-asserted-by":"publisher","first-page":"832501","DOI":"10.3389\/fimmu.2022.832501","volume":"13","author":"SR Hamm","year":"2022","unstructured":"Hamm SR, M\u00f8ller DL, P\u00e9rez-Al\u00f3s L et al (2022) Decline in antibody concentration 6 months after two doses of SARS-CoV-2 BNT162b2 vaccine in solid organ transplant recipients and healthy controls. Front Immunol 13:832501","journal-title":"Front Immunol"},{"key":"6565_CR33","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/v15071553","volume":"15","author":"JK Lalia","year":"2023","unstructured":"Lalia JK, Schild R, L\u00fctgehetmann M et al (2023) Reduced humoral and cellular immune response to primary COVID-19 mRNA vaccination in kidney transplanted children aged 5\u201311 years. Viruses 15:1553","journal-title":"Viruses"},{"key":"6565_CR34","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3390\/vaccines11040724","volume":"11","author":"KI Notarte","year":"2023","unstructured":"Notarte KI, Catahay JA, Peligro PJ et al (2023) Humoral response in hemodialysis patients post-SARS-CoV-2 mRNA vaccination: a systematic review of literature. Vaccines (Basel) 11:724","journal-title":"Vaccines (Basel)"},{"key":"6565_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40001-022-00648-5","volume":"27","author":"M-M Mehrabi Nejad","year":"2022","unstructured":"Mehrabi Nejad M-M, Moosaie F, Dehghanbanadaki H et al (2022) Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 27:23. https:\/\/doi.org\/10.1186\/s40001-022-00648-5","journal-title":"Eur J Med Res"},{"key":"6565_CR36","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00467-022-05633-y","volume":"38","author":"K Kamei","year":"2023","unstructured":"Kamei K, Ogura M, Sato M et al (2023) Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents. Pediatr Nephrol 38:1099\u20131106","journal-title":"Pediatr Nephrol"},{"key":"6565_CR37","unstructured":"Ministry of Health (2023) COVID-19 vaccine guidance. https:\/\/www.ontario.ca\/files\/2023-12\/moh-covid-19-vaccine-guidance-en-2023-12-22.pdf. Accessed 1 September 2024"},{"key":"6565_CR38","doi-asserted-by":"publisher","first-page":"e2310650","DOI":"10.1001\/jamanetworkopen.2023.10650","volume":"6","author":"F Menegale","year":"2023","unstructured":"Menegale F, Manica M, Zardini A et al (2023) Evaluation of waning of SARS-CoV-2 vaccine-induced immunity: a systematic review and meta-analysis. JAMA Netw Open 6:e2310650","journal-title":"JAMA Netw Open"},{"key":"6565_CR39","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin DR, Higdon MM, Abu-Raddad LJ et al (2022) Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 399:924\u2013944","journal-title":"Lancet"},{"key":"6565_CR40","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1007\/s00467-022-05806-9","volume":"38","author":"M Stich","year":"2023","unstructured":"Stich M, Di Cristanziano V, T\u00f6nshoff B et al (2023) Humoral immune response and live-virus neutralization of the SARS-CoV-2 omicron (BA.1) variant after COVID-19 mRNA vaccination in children and young adults with chronic kidney disease. Pediatr Nephrol 38:1935\u20131948","journal-title":"Pediatr Nephrol"},{"key":"6565_CR41","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.3390\/vaccines10111807","volume":"10","author":"J Li","year":"2022","unstructured":"Li J, Liu Q, Liu J et al (2022) Development of bivalent mRNA vaccines against SARS-CoV-2 variants. Vaccines (Basel) 10:1807","journal-title":"Vaccines (Basel)"},{"key":"6565_CR42","unstructured":"US Food and Drug Administration (2023) Moderna COVID-19 vaccine: Moderna COVID-19 vaccine (2023\u20132024 formula) authorized for individuals 6 months through 11 years of Age. https:\/\/www.fda.gov\/vaccines-blood-biologics\/coronavirus-covid-19-cber-regulated-biologics\/moderna-covid-19-vaccine. Accessed 6 September 2024"},{"key":"6565_CR43","unstructured":"US Food and Drug Administration (2023) Pfizer-BioNTech COVID-19 vaccine (2023\u20132024 formula) authorized for individuals 6 months through 11 years of age. https:\/\/www.fda.gov\/vaccines-blood-biologics\/coronavirus-covid-19-cber-regulated-biologics\/pfizer-biontech-covid-19-vaccine. Accessed 6 September 2024"},{"key":"6565_CR44","unstructured":"National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases (2023) Stay up to date with COVID-19 vaccines. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/stay-up-to-date.html. Accessed 7 September 2024"},{"key":"6565_CR45","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","volume":"396","author":"GA Poland","year":"2020","unstructured":"Poland GA, Ovsyannikova IG, Kennedy RB (2020) SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates. Lancet 396:1595\u20131606","journal-title":"Lancet"},{"key":"6565_CR46","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A et al (2021) Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med 27:1205\u20131211","journal-title":"Nat Med"},{"key":"6565_CR47","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle KA, Ambrosino DM, Fiore-Gartland A et al (2021) Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine 39:4423\u20134428","journal-title":"Vaccine"},{"key":"6565_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.vaccine.2021.12.006","volume":"40","author":"D Goldblatt","year":"2022","unstructured":"Goldblatt D, Fiore-Gartland A, Johnson M et al (2022) Towards a population-based threshold of protection for COVID-19 vaccines. Vaccine 40:306\u2013315","journal-title":"Vaccine"},{"key":"6565_CR49","doi-asserted-by":"publisher","first-page":"108095","DOI":"10.1016\/j.intimp.2021.108095","volume":"100","author":"M Infantino","year":"2021","unstructured":"Infantino M, Pieri M, Nuccetelli M et al (2021) The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays. Int Immunopharmacol 100:108095","journal-title":"Int Immunopharmacol"},{"key":"6565_CR50","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng S, Phillips DJ, White T et al (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med 27:2032\u20132040. https:\/\/doi.org\/10.1038\/s41591-021-01540-1","journal-title":"Nat Med"},{"key":"6565_CR51","doi-asserted-by":"publisher","unstructured":"(2022) Why hybrid immunity is so triggering. Lancet Infect Dis 22:1649. https:\/\/doi.org\/10.1016\/S1473-3099(22)00746-0","DOI":"10.1016\/S1473-3099(22)00746-0"},{"key":"6565_CR52","doi-asserted-by":"publisher","first-page":"103589","DOI":"10.1016\/j.ebiom.2021.103589","volume":"72","author":"B Appelman","year":"2021","unstructured":"Appelman B, van der Straten K, Lavell AHA et al (2021) Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination. EBioMedicine 72:103589","journal-title":"EBioMedicine"},{"key":"6565_CR53","doi-asserted-by":"publisher","first-page":"110336","DOI":"10.1016\/j.celrep.2022.110336","volume":"38","author":"TM Narowski","year":"2022","unstructured":"Narowski TM, Raphel K, Adams LE et al (2022) SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Cell Rep 38:110336","journal-title":"Cell Rep"},{"issue":"3","key":"6565_CR54","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1101\/2021.05.07.21256823","volume":"53","author":"G Floriane","year":"2021","unstructured":"Floriane G, Pierre G, Timoth\u00e9e B et al (2021) Anti-SARS-CoV-2 antibodies persist for up to 13 months and reduce risk of reinfection. medRxiv 53(3):524. https:\/\/doi.org\/10.1101\/2021.05.07.21256823","journal-title":"medRxiv"},{"key":"6565_CR55","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/S1473-3099(22)00801-5","volume":"23","author":"N Bobrovitz","year":"2023","unstructured":"Bobrovitz N, Ware H, Ma X et al (2023) Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression. Lancet Infect Dis 23:556\u2013567","journal-title":"Lancet Infect Dis"},{"key":"6565_CR56","first-page":"1467","volume":"9","author":"HHL Wu","year":"2022","unstructured":"Wu HHL, Shenoy M, Kalra PA, Chinnadurai R (2022) Intrinsic kidney pathology in children and adolescents following COVID-19 vaccination: a systematic review. Children (Basel) 9:1467","journal-title":"Children (Basel)"},{"key":"6565_CR57","doi-asserted-by":"publisher","unstructured":"Waldman M, Sinaii N, Lerma EV et al (2023) COVID-19 Vaccination and new onset glomerular disease: results from the IRocGN2 international registry. Kidney360 4:349\u2013362. https:\/\/doi.org\/10.34067\/kid.0006832022","DOI":"10.34067\/kid.0006832022"},{"key":"6565_CR58","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","volume":"27","author":"S Feng","year":"2021","unstructured":"Feng S, Phillips DJ, White T et al (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med 27:2032\u20132040","journal-title":"Nat Med"},{"key":"6565_CR59","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/qjmed\/hcac185","volume":"116","author":"Y Ma","year":"2023","unstructured":"Ma Y, Xu G (2023) New-onset IgA nephropathy following COVID-19 vaccination. QJM 116:26\u201339. https:\/\/doi.org\/10.1093\/qjmed\/hcac185","journal-title":"QJM"},{"key":"6565_CR60","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s00467-021-05249-8","volume":"37","author":"EC Bjornstad","year":"2022","unstructured":"Bjornstad EC, Seifert ME, Sanderson K, Feig DI (2022) Kidney implications of SARS-CoV2 infection in children. Pediatr Nephrol 37:1453\u20131467. https:\/\/doi.org\/10.1007\/s00467-021-05249-8","journal-title":"Pediatr Nephrol"},{"key":"6565_CR61","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00467-021-05218-1","volume":"37","author":"S Krishnasamy","year":"2022","unstructured":"Krishnasamy S, Mantan M, Mishra K et al (2022) SARS-CoV-2 infection in children with chronic kidney disease. Pediatr Nephrol 37:849\u2013857","journal-title":"Pediatr Nephrol"},{"key":"6565_CR62","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40620-021-01171-2","volume":"35","author":"J Weinbrand-Goichberg","year":"2022","unstructured":"Weinbrand-Goichberg J, Ben Shalom E, Rinat C et al (2022) COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response. J Nephrol 35:121\u2013129","journal-title":"J Nephrol"},{"key":"6565_CR63","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00467-021-05330-2","volume":"37","author":"W Morello","year":"2022","unstructured":"Morello W, Vianello FA, Proverbio E et al (2022) COVID-19 and idiopathic nephrotic syndrome in children: systematic review of the literature and recommendations from a highly affected area. Pediatr Nephrol 37:757\u2013764","journal-title":"Pediatr Nephrol"},{"key":"6565_CR64","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00467-020-04597-1","volume":"35","author":"M Melgosa","year":"2020","unstructured":"Melgosa M, Madrid A, Alv\u00e1rez O et al (2020) SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol 35:1521\u20131524","journal-title":"Pediatr Nephrol"},{"key":"6565_CR65","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.mpsur.2021.10.003","volume":"39","author":"SJ Dancer","year":"2021","unstructured":"Dancer SJ (2021) Reducing the risk of COVID-19 transmission in hospitals: focus on additional infection control strategies. Surgery (Oxf) 39:752\u2013758","journal-title":"Surgery (Oxf)"},{"key":"6565_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/HYPERTENSIONAHA.111.189266","volume":"60","author":"J Samuels","year":"2012","unstructured":"Samuels J, Ng D, Flynn JT et al (2012) Ambulatory blood pressure patterns in children with chronic kidney disease. Hypertension 60:43\u201350","journal-title":"Hypertension"},{"key":"6565_CR67","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12887-023-04304-7","volume":"23","author":"S Sadiq","year":"2023","unstructured":"Sadiq S, Black E, Oates A (2023) Identifying barriers and utility of obtaining ambulatory blood pressure monitoring in a pediatric chronic kidney disease population. BMC Pediatr 23:469","journal-title":"BMC Pediatr"},{"key":"6565_CR68","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/hdi.12876","volume":"25","author":"A Rawson","year":"2021","unstructured":"Rawson A, Wilson AC, Schwaderer AL et al (2021) Coronavirus disease 2019 (COVID-19) in two pediatric patients with kidney disease on chronic immunosuppression: a case series. Hemodial Int 25:E1\u2013E5","journal-title":"Hemodial Int"},{"key":"6565_CR69","doi-asserted-by":"publisher","unstructured":"Yiqiong M, Bo D, Xifeng L et al (2020) COVID-19 in hemodialysis (HD) patients: report from one HD center in Wuhan, China. medRxiv:2020.02.24.20027201. https:\/\/doi.org\/10.1101\/2020.02.24.20027201","DOI":"10.1101\/2020.02.24.20027201"},{"key":"6565_CR70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00431-021-04191-z","volume":"181","author":"N Canpolat","year":"2022","unstructured":"Canpolat N, Y\u0131ld\u0131r\u0131m ZY, Y\u0131ld\u0131z N et al (2022) COVID-19 in pediatric patients undergoing chronic dialysis and kidney transplantation. Eur J Pediatr 181:117\u2013123","journal-title":"Eur J Pediatr"},{"key":"6565_CR71","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2215\/CJN.03420320","volume":"15","author":"J Li","year":"2020","unstructured":"Li J, Xu G (2020) Lessons from the experience in Wuhan to reduce risk of COVID-19 infection in patients undergoing long-term hemodialysis. Clin J Am Soc Nephrol 15:717\u2013719","journal-title":"Clin J Am Soc Nephrol"},{"key":"6565_CR72","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2215\/CJN.03340320","volume":"15","author":"AS Kliger","year":"2020","unstructured":"Kliger AS, Silberzweig J (2020) Mitigating risk of COVID-19 in dialysis facilities. Clin J Am Soc Nephrol 15:707\u2013709","journal-title":"Clin J Am Soc Nephrol"},{"key":"6565_CR73","unstructured":"Centers for Disease Control and Prevention: National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases (2023) Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/infection-control-recommendations.html. Accessed 5 September 2023"},{"key":"6565_CR74","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00467-020-04555-x","volume":"35","author":"Q Shen","year":"2020","unstructured":"Shen Q, Wang M, Che R et al (2020) Consensus recommendations for the care of children receiving chronic dialysis in association with the COVID-19 epidemic. Pediatr Nephrol 35:1351\u20131357","journal-title":"Pediatr Nephrol"},{"key":"6565_CR75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","volume":"36","author":"ERA-EDTA Council; ERACODA Working Group","year":"2021","unstructured":"ERA-EDTA Council; ERACODA Working Group (2021) Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA. Nephrol Dial Transplant 36:87\u201394. https:\/\/doi.org\/10.1093\/ndt\/gfaa314","journal-title":"Nephrol Dial Transplant"},{"key":"6565_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/ijn.IJN_192_20","volume":"30","author":"T Jeloka","year":"2020","unstructured":"Jeloka T, Gupta A, Prasad N et al (2020) Peritoneal dialysis patients during COVID 19 pandemic. Indian J Nephrol 30:171\u2013173","journal-title":"Indian J Nephrol"},{"key":"6565_CR77","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/ijn.IJN_166_20","volume":"30","author":"V Lobo","year":"2020","unstructured":"Lobo V, Khanna U, Rajapurkar M et al (2020) Guidelines for dialysis with reference to COVID-19. Indian J Nephrol 30:166\u2013170","journal-title":"Indian J Nephrol"},{"key":"6565_CR78","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/archdischild-2020-320616","volume":"106","author":"M Marlais","year":"2020","unstructured":"Marlais M, Wlodkowski T, Al-Akash S et al (2020) COVID-19 in children treated with immunosuppressive medication for kidney diseases. Arch Dis Child 106:798\u2013801","journal-title":"Arch Dis Child"},{"key":"6565_CR79","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s00467-022-05570-w","volume":"38","author":"C Varnell Jr","year":"2023","unstructured":"Varnell C Jr, Harshman LA, Liu C et al (2023) COVID-19 in pediatric kidney transplantation: a follow-up report of the improving renal outcomes collaborative. Pediatr Nephrol 38:537\u2013547","journal-title":"Pediatr Nephrol"},{"key":"6565_CR80","doi-asserted-by":"publisher","first-page":"e14063","DOI":"10.1111\/ctr.14063","volume":"34","author":"D Don\u00e1","year":"2020","unstructured":"Don\u00e1 D, Torres Canizales J, Benetti E et al (2020) Pediatric transplantation in Europe during the COVID-19 pandemic: early impact on activity and healthcare. Clin Transplant 34:e14063","journal-title":"Clin Transplant"},{"key":"6565_CR81","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/lt.25756","volume":"26","author":"L D'Antiga","year":"2020","unstructured":"D\u2019Antiga L (2020) Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl 26:832\u2013834","journal-title":"Liver Transpl"},{"key":"6565_CR82","doi-asserted-by":"publisher","first-page":"e14013","DOI":"10.1111\/petr.14013","volume":"25","author":"E Levenson","year":"2021","unstructured":"Levenson E, Shepherd TN, Aviles D et al (2021) De novo collapsing glomerulopathy in a pediatric kidney transplant recipient with COVID-19 infection. Pediatr Transplant 25:e14013","journal-title":"Pediatr Transplant"},{"key":"6565_CR83","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1111\/ajt.16464","volume":"21","author":"L Berteloot","year":"2021","unstructured":"Berteloot L, Berthaud R, Temmam S et al (2021) Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic. Am J Transplant 21:1937\u20131943","journal-title":"Am J Transplant"},{"key":"6565_CR84","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1097\/tp.0000000000003774","volume":"105","author":"J Hogan","year":"2021","unstructured":"Hogan J, Kwon T, Paye-Jaouen A et al (2021) Kidney transplantation in a COVID-19-positive pediatric recipient. Transplantation 105:e74\u2013e75. https:\/\/doi.org\/10.1097\/tp.0000000000003774","journal-title":"Transplantation"},{"key":"6565_CR85","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.3389\/ti.2023.11153","volume":"36","author":"I Nel","year":"2023","unstructured":"Nel I, Parmentier C, Dehoux L et al (2023) Optimizing COVID-19 vaccination strategy in pediatric kidney transplant recipients: humoral and cellular response to SARS-CoV-2 mRNA vaccination. Transpl Int 36:11153","journal-title":"Transpl Int"},{"key":"6565_CR86","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/ajt.16905","volume":"22","author":"MZ Molnar","year":"2022","unstructured":"Molnar MZ, Hall IE, Raghavan D et al (2022) Kidney transplantation from SARS-CoV-2-positive deceased donor. Am J Transplant 22:1280\u20131282","journal-title":"Am J Transplant"},{"key":"6565_CR87","doi-asserted-by":"publisher","first-page":"101098","DOI":"10.1016\/j.accpm.2022.101098","volume":"41","author":"R Martinez-Reviejo","year":"2022","unstructured":"Martinez-Reviejo R, Tejada S, Cipriano A et al (2022) Solid organ transplantation from donors with recent or current SARS-CoV-2 infection: a systematic review. Anaesth Crit Care Pain Med 41:101098","journal-title":"Anaesth Crit Care Pain Med"},{"key":"6565_CR88","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1111\/ajt.17203","volume":"22","author":"CE Koval","year":"2022","unstructured":"Koval CE, Eltemamy M, Poggio ED et al (2022) Comparative outcomes for over 100 deceased donor kidney transplants from SARS-CoV-2 positive donors: a single-center experience. Am J Transplant 22:2903\u20132911","journal-title":"Am J Transplant"},{"key":"6565_CR89","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/0886022x.2021.1931319","volume":"43","author":"H Ali","year":"2021","unstructured":"Ali H, Mohamed M, Molnar MZ, Krishnan N (2021) Is it safe to receive kidneys from deceased kidney donors tested positive for Covid-19 infection? Ren Fail 43:1060\u20131062. https:\/\/doi.org\/10.1080\/0886022x.2021.1931319","journal-title":"Ren Fail"},{"key":"6565_CR90","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1590\/2175-8239-jbn-2020-0208","volume":"43","author":"BCD Faria","year":"2021","unstructured":"Faria BCD, Sacramento LGG, Filipin CSA et al (2021) An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19. J Bras Nefrol 43:400\u2013409. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2020-0208","journal-title":"J Bras Nefrol"},{"key":"6565_CR91","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1590\/2175-8239-jbn-2020-0208","volume":"68","author":"M Havrda","year":"2022","unstructured":"Havrda M (2022) Glomerulonephritides associated with infections. Vnitr Lek 68:432\u2013437. https:\/\/doi.org\/10.1590\/2175-8239-jbn-2020-0208","journal-title":"Vnitr Lek"},{"key":"6565_CR92","doi-asserted-by":"publisher","first-page":"571","DOI":"10.55730\/1300-0144.5348","volume":"52","author":"\u0130C Erba\u015f","year":"2022","unstructured":"Erba\u015f \u0130C, Asrak HK, G\u00fczin A et al (2022) The clinical follow-up and management of COVID-19 in children and adolescents with an immunocompromised state or a malignancy. Turk J Med Sci 52:571\u2013579","journal-title":"Turk J Med Sci"},{"key":"6565_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s15010-022-01826-7","volume":"51","author":"L Pilgram","year":"2023","unstructured":"Pilgram L, Eberwein L, Jensen B-EO et al (2023) SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality). Infection 51:71\u201381. https:\/\/doi.org\/10.1007\/s15010-022-01826-7","journal-title":"Infection"},{"key":"6565_CR94","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/cells10123580","volume":"10","author":"R Raina","year":"2021","unstructured":"Raina R, Vijayvargiya N, Khooblall A et al (2021) Pediatric atypical hemolytic uremic syndrome advances. Cells 10:3580","journal-title":"Cells"},{"key":"6565_CR95","doi-asserted-by":"publisher","first-page":"E1155","DOI":"10.1503\/cmaj.220620","volume":"194","author":"VG Hall","year":"2022","unstructured":"Hall VG, Solera JT, Al-Alahmadi G et al (2022) Severity of COVID-19 among solid organ transplant recipients in Canada, 2020\u20132021: a prospective, multicentre cohort study. CMAJ 194:E1155\u2013E1163. https:\/\/doi.org\/10.1503\/cmaj.220620","journal-title":"CMAJ"},{"key":"6565_CR96","doi-asserted-by":"publisher","first-page":"e13868","DOI":"10.1111\/petr.13868","volume":"25","author":"MB Goss","year":"2021","unstructured":"Goss MB, Galv\u00e1n NTN, Ruan W et al (2021) The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multi-organ case series. Pediatr Transplant 25:e13868","journal-title":"Pediatr Transplant"},{"key":"6565_CR97","first-page":"10","volume":"59","author":"I Hasan","year":"2021","unstructured":"Hasan I, Rashid T, Suliman S et al (2021) Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample. Rom J Intern Med 59:10\u201342","journal-title":"Rom J Intern Med"},{"key":"6565_CR98","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.anpedi.2021.07.014","volume":"97","author":"RM Wong-Chew","year":"2022","unstructured":"Wong-Chew RM, Noyola DE, Villa AR (2022) Clinical characteristics and mortality risk factors in patients aged less than 18 years with COVID-19 in Mexico and Mexico City. An Pediatr (Engl Ed) 97:119\u2013128","journal-title":"An Pediatr (Engl Ed)"},{"key":"6565_CR99","first-page":"100184","volume":"8","author":"C Sanchez-Piedra","year":"2022","unstructured":"Sanchez-Piedra C, Gami\u00f1o-Arroyo AE, Cruz-Cruz C, Prado-Galbarro FJ (2022) Impact of environmental and individual factors on COVID-19 mortality in children and adolescents in Mexico: an observational study. Lancet Reg Health Am 8:100184","journal-title":"Lancet Reg Health Am"},{"key":"6565_CR100","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpeds.2022.02.048","volume":"245","author":"JI Campbell","year":"2022","unstructured":"Campbell JI, Dubois MM, Savage TJ et al (2022) Comorbidities associated with hospitalization and progression among adolescents with symptomatic coronavirus disease 2019. J Pediatr 245:102\u201310.e2","journal-title":"J Pediatr"},{"key":"6565_CR101","doi-asserted-by":"publisher","first-page":"e13972","DOI":"10.1111\/petr.13972","volume":"25","author":"S Solomon","year":"2021","unstructured":"Solomon S, Pereira T, Samsonov D (2021) An early experience of COVID-19 disease in pediatric and young adult renal transplant recipients. Pediatr Transplant 25:e13972","journal-title":"Pediatr Transplant"},{"key":"6565_CR102","doi-asserted-by":"publisher","first-page":"582932","DOI":"10.3389\/fpubh.2020.582932","volume":"8","author":"OP Mehta","year":"2020","unstructured":"Mehta OP, Bhandari P, Raut A et al (2020) Coronavirus disease (COVID-19): comprehensive review of clinical presentation. Front Public Health 8:582932","journal-title":"Front Public Health"},{"key":"6565_CR103","doi-asserted-by":"publisher","first-page":"e14887","DOI":"10.1111\/ped.14887","volume":"64","author":"G Erfidan","year":"2022","unstructured":"Erfidan G, \u00d6zyurt G, Arslansoyu-\u00c7amlar S et al (2022) Is coronavirus pandemic-related anxiety higher in children with chronic kidney disease than healthy children? Pediatr Int 64:e14887. https:\/\/doi.org\/10.1111\/ped.14887","journal-title":"Pediatr Int"},{"key":"6565_CR104","doi-asserted-by":"publisher","first-page":"922678","DOI":"10.3389\/fpubh.2022.922678","volume":"10","author":"HY Xiong","year":"2022","unstructured":"Xiong HY, Zhang G, Wang L et al (2022) Psychological research of the children with chronic kidney disease and their guardians during the COVID-19 pandemic. Front Public Health 10:922678","journal-title":"Front Public Health"},{"key":"6565_CR105","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.xkme.2020.09.007","volume":"3","author":"A Basalely","year":"2021","unstructured":"Basalely A, Brathwaite K, Duong MD et al (2021) COVID-19 in children with kidney disease: a report of 2 cases. Kidney Med 3:120\u2013123","journal-title":"Kidney Med"},{"key":"6565_CR106","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1111\/bcp.15338","volume":"88","author":"S Selvarajan","year":"2022","unstructured":"Selvarajan S, Anandaradje A, Shivabasappa S et al (2022) Efficacy of pharmacological interventions in COVID-19: a network meta-analysis. Br J Clin Pharmacol 88:4080\u20134091","journal-title":"Br J Clin Pharmacol"},{"key":"6565_CR107","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","volume":"324","author":"DC Angus","year":"2020","unstructured":"Angus DC, Derde L, Al-Beidh F et al (2020) Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA 324:1317\u20131329. https:\/\/doi.org\/10.1001\/jama.2020.17022","journal-title":"JAMA"},{"key":"6565_CR108","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/23744235.2021.1923799","volume":"53","author":"GN Okoli","year":"2021","unstructured":"Okoli GN, Rabbani R, Copstein L et al (2021) Remdesivir for coronavirus disease 2019 (COVID-19): a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials. Infect Dis (Lond) 53:691\u2013699","journal-title":"Infect Dis (Lond)"},{"key":"6565_CR109","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s15010-021-01671-0","volume":"50","author":"MT Angamo","year":"2022","unstructured":"Angamo MT, Mohammed MA, Peterson GM (2022) Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis. Infection 50:27\u201341","journal-title":"Infection"},{"key":"6565_CR110","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1574886316666210728110330","volume":"17","author":"M Konwar","year":"2022","unstructured":"Konwar M, Maurya M, Bose D (2022) A meta-analysis of safety of different regimens of remdesivir in COVID-19 patients. Curr Drug Saf 17:158\u2013167. https:\/\/doi.org\/10.2174\/1574886316666210728110330","journal-title":"Curr Drug Saf"},{"key":"6565_CR111","unstructured":"US Food and Drug Administration (2023) Remdesivir (Veklury) [package insert]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/214787s019lbl.pdf. Accessed 10 July 2024"},{"key":"6565_CR112","doi-asserted-by":"publisher","first-page":"9528471","DOI":"10.1002\/jmv.28471","volume":"95","author":"HA Cheema","year":"2023","unstructured":"Cheema HA, Jafar U, Sohail A et al (2023) Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: a systematic review and meta-analysis. J Med Virol 95:9528471. https:\/\/doi.org\/10.1002\/jmv.28471","journal-title":"J Med Virol"},{"key":"6565_CR113","doi-asserted-by":"publisher","first-page":"e28441","DOI":"10.1002\/jmv.28441","volume":"95","author":"B Amani","year":"2023","unstructured":"Amani B, Amani B (2023) Efficacy and safety of nirmatrelvir\/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis. J Med Virol 95:e28441. https:\/\/doi.org\/10.1002\/jmv.28441","journal-title":"J Med Virol"},{"key":"6565_CR114","doi-asserted-by":"publisher","first-page":"101489","DOI":"10.1016\/j.eclinm.2022.101489","volume":"49","author":"V Selvaraj","year":"2022","unstructured":"Selvaraj V, Finn A, Lal A et al (2022) Baricitinib in hospitalised patients with COVID-19: a meta-analysis of randomised controlled trials. EClinicalMedicine 49:101489","journal-title":"EClinicalMedicine"},{"key":"6565_CR115","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00228-021-03087-z","volume":"77","author":"CS Kow","year":"2021","unstructured":"Kow CS, Hasan SS (2021) The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 77:1089\u20131094","journal-title":"Eur J Clin Pharmacol"},{"key":"6565_CR116","doi-asserted-by":"publisher","first-page":"17561","DOI":"10.1038\/s41598-022-22431-6","volume":"12","author":"D McConnell","year":"2022","unstructured":"McConnell D, Harte M, Walsh C et al (2022) Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis. Sci Rep 12:17561. https:\/\/doi.org\/10.1038\/s41598-022-22431-6","journal-title":"Sci Rep"},{"key":"6565_CR117","first-page":"Cd013587","volume":"2","author":"B Singh","year":"2021","unstructured":"Singh B, Ryan H, Kredo T et al (2021) Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database Syst Rev 2:Cd013587","journal-title":"Cochrane Database Syst Rev"},{"key":"6565_CR118","doi-asserted-by":"crossref","unstructured":"Aliyu B, Raji YE, Chee HY et al (2022) Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19). PLoS One 17:e0277206","DOI":"10.1371\/journal.pone.0277206"},{"key":"6565_CR119","unstructured":"COVID-19 Treatment guidelines panel. National Institutes of Health (2023) Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570371\/pdf\/Bookshelf_NBK570371.pdf. Accessed 1 March 2023"},{"key":"6565_CR120","doi-asserted-by":"publisher","first-page":"2275912","DOI":"10.1080\/16078454.2023.2275912","volume":"28","author":"D Xie","year":"2023","unstructured":"Xie D, Xue X, Qiao W et al (2023) Thrombotic events and prophylactic anticoagulation in pediatric patients with COVID-19: a systematic review and meta-analysis. Hematology 28:2275912","journal-title":"Hematology"},{"key":"6565_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3400\/avd.oa.23-00031","volume":"17","author":"Y Yamashita","year":"2024","unstructured":"Yamashita Y, Yachi S, Takeyama M et al (2024) Prophylactic anticoagulation and thrombosis in hospitalized patients with clinically stable COVID-19 at admission: from the practice-based observational study. Ann Vasc Dis 17:1\u20138","journal-title":"Ann Vasc Dis"},{"key":"6565_CR122","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/17474086.2022.2094758","volume":"15","author":"G Vitaliti","year":"2022","unstructured":"Vitaliti G, Giacchi V, Sciacca M et al (2022) Thrombotic events in children and adolescent patients with SARS-CoV-2 infection: a systematic review with meta-analysis on incidence and management. Expert Rev Hematol 15:635\u2013643","journal-title":"Expert Rev Hematol"},{"key":"6565_CR123","unstructured":"Pfizer Canada ULC (2023) Product monograph including patient medication information, Prpaxlovid\u2122 nirmatrelvir tablets; ritonavir tablets. https:\/\/covid-vaccine.canada.ca\/info\/pdf\/paxlovid-pm-en.pdf. Accessed 10 July 2024"},{"key":"6565_CR124","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2215\/CJN.05270522","volume":"17","author":"S Hiremath","year":"2022","unstructured":"Hiremath S, McGuinty M, Argyropoulos C et al (2022) Prescribing nirmatrelvir\/ritonavir for COVID-19 in advanced CKD. Clin J Am Soc Nephrol 17:1247\u20131250","journal-title":"Clin J Am Soc Nephrol"},{"key":"6565_CR125","doi-asserted-by":"publisher","unstructured":"Gonzalez-Garc\u00eda R, Roma J-R, Rodr\u00edguez-Garc\u00eda M et al (2023) Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. Clin Microbiol Infect 29:6550.e1\u2013655.e4. https:\/\/doi.org\/10.1016\/j.cmi.2023.01.002","DOI":"10.1016\/j.cmi.2023.01.002"},{"key":"6565_CR126","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00467-022-05712-0","volume":"38","author":"C Young","year":"2023","unstructured":"Young C, Papiro T, Greenberg JH (2023) Elevated tacrolimus levels after treatment with nirmatrelvir\/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant. Pediatr Nephrol 38:1387\u20131388","journal-title":"Pediatr Nephrol"},{"key":"6565_CR127","doi-asserted-by":"publisher","first-page":"20958","DOI":"10.1038\/s41598-020-78029-3","volume":"10","author":"J Mac\u00edas","year":"2020","unstructured":"Mac\u00edas J, Pinilla A, Lao-Dominguez FA et al (2020) High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment. Sci Rep 10:20958","journal-title":"Sci Rep"},{"key":"6565_CR128","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s40266-020-00812-8","volume":"37","author":"D Cattaneo","year":"2020","unstructured":"Cattaneo D, Pasina L, Maggioni AP et al (2020) Drug-drug interactions and prescription appropriateness in patients with COVID-19: a retrospective analysis from a reference hospital in Northern Italy. Drugs Aging 37:925\u2013933","journal-title":"Drugs Aging"},{"key":"6565_CR129","doi-asserted-by":"publisher","first-page":"e13286","DOI":"10.1111\/tid.13286","volume":"22","author":"M Bartiromo","year":"2020","unstructured":"Bartiromo M, Borchi B, Botta A et al (2020) Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19). Transpl Infect Dis 22:e13286","journal-title":"Transpl Infect Dis"},{"key":"6565_CR130","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1556\/650.2020.31923","volume":"161","author":"\u00c1 Remport","year":"2020","unstructured":"Remport \u00c1, Gerlei Z, Cseprek\u00e1l O et al (2020) Guidance on the special care of liver or kidney transplant recipients diagnosed with COVID-19. Orv Hetil 161:1310\u20131321. https:\/\/doi.org\/10.1556\/650.2020.31923","journal-title":"Orv Hetil"},{"key":"6565_CR131","doi-asserted-by":"publisher","first-page":"e252677","DOI":"10.1136\/bcr-2022-252677","volume":"16","author":"OI Haque","year":"2023","unstructured":"Haque OI, Mahar S, Hussain S, Sloane P (2023) Pharmacokinetic interaction between verapamil and ritonavir-boosted nirmatrelvir: implications for the management of COVID-19 in patients with hypertension. BMJ Case Rep 16:e252677","journal-title":"BMJ Case Rep"},{"key":"6565_CR132","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1111\/ajt.15947","volume":"20","author":"Y Kim","year":"2020","unstructured":"Kim Y, Kwon O, Paek JH et al (2020) Two distinct cases with COVID-19 in kidney transplant recipients. Am J Transplant 20:2269\u20132275","journal-title":"Am J Transplant"},{"key":"6565_CR133","first-page":"569","volume":"105","author":"KE Lindauer","year":"2022","unstructured":"Lindauer KE, Hamel AG (2022) Case report: nirmatrelvir\/ritonavir and tacrolimus in a kidney transplant recipient with COVID-19. Am Fam Physician 105:569\u2013570","journal-title":"Am Fam Physician"},{"key":"6565_CR134","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40261-022-01180-4","volume":"42","author":"N Berar Yanay","year":"2022","unstructured":"Berar Yanay N, Bogner I, Saker K, Tannous E (2022) Paxlovid-tacrolimus drug-drug interaction in a 23-year-old female kidney transplant patient with COVID-19. Clin Drug Investig 42:693\u2013695","journal-title":"Clin Drug Investig"},{"key":"6565_CR135","doi-asserted-by":"publisher","first-page":"e14752","DOI":"10.1111\/ctr.14752","volume":"36","author":"K Mecadon","year":"2022","unstructured":"Mecadon K, Arvanitis P, Farmakiotis D, Rogers R (2022) Single-center experience with nirmatrelvir\/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression. Clin Transplant 36:e14752","journal-title":"Clin Transplant"},{"key":"6565_CR136","doi-asserted-by":"publisher","first-page":"ofac238","DOI":"10.1093\/ofid\/ofac238","volume":"9","author":"DT Rose","year":"2022","unstructured":"Rose DT, Gandhi SM, Bedard RA et al (2022) Supratherapeutic tacrolimus concentrations with nirmatrelvir\/ritonavir in solid organ transplant recipients requiring hospitalization: a case series using rifampin for reversal. Open Forum Infect Dis 9:ofac238","journal-title":"Open Forum Infect Dis"},{"key":"6565_CR137","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/ftd.0000000000001014","volume":"45","author":"F Lemaitre","year":"2023","unstructured":"Lemaitre F, Budde K, Van Gelder T et al (2023) Therapeutic drug monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir\/ritonavir in patients with COVID-19. Ther Drug Monit 45:191\u2013199. https:\/\/doi.org\/10.1097\/ftd.0000000000001014","journal-title":"Ther Drug Monit"},{"key":"6565_CR138","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/ajt.17027","volume":"22","author":"DM Salerno","year":"2022","unstructured":"Salerno DM, Jennings DL, Lange NW et al (2022) Early clinical experience with nirmatrelvir\/ritonavir for the treatment of COVID-19 in solid organ transplant recipients. Am J Transplant 22:2083\u20132088","journal-title":"Am J Transplant"},{"key":"6565_CR139","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/ftd.0000000000001046","volume":"45","author":"YA Djaelani","year":"2023","unstructured":"Djaelani YA, Giese T, Sommerer C, Czock D (2023) Pharmacodynamic monitoring of ciclosporin and tacrolimus: insights from nuclear factor of activated T-cell-regulated gene expression in healthy volunteers. Ther Drug Monit 45:87\u201394. https:\/\/doi.org\/10.1097\/ftd.0000000000001046","journal-title":"Ther Drug Monit"},{"key":"6565_CR140","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3238\/arztebl.m2022.0152","volume":"119","author":"G Mikus","year":"2022","unstructured":"Mikus G, Foerster KI, Terstegen T et al (2022) Oral drugs against COVID-19. Dtsch Arztebl Int 119:263\u2013269. https:\/\/doi.org\/10.3238\/arztebl.m2022.0152","journal-title":"Dtsch Arztebl Int"},{"key":"6565_CR141","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es ESAC, Vasconcelos MA, Colosimo EA et al (2022) Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID-19 in Brazil: An analysis of a nationwide database. Pediatr Obes 17:e12920","DOI":"10.1111\/ijpo.12920"},{"key":"6565_CR142","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1177\/0896860820953716","volume":"40","author":"M McCulloch","year":"2020","unstructured":"McCulloch M, Abugrain K, Mosalakatane T et al (2020) Peritoneal dialysis for treatment of acute kidney injury in a case of paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. Perit Dial Int 40:515\u2013517","journal-title":"Perit Dial Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06565-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:24:03Z","timestamp":1743467043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06565-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6565"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06565-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,29]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}